MYUNGMOON Pharm co.,Ltd

KRX:017180.KS

2135 (KRW) • At close November 1, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Omzet 169,567.373152,134.941137,759.902127,852.856149,346.277147,498.532140,137.943142,179.739125,100.92105,420.702103,723.479100,538.969125,619.902105,183.28997,191.21977,390.4360,927.94
Kosten van de omzet 75,051.80174,034.14275,422.11678,861.73180,912.96773,048.38460,933.13766,001.43762,422.14151,254.83352,634.73453,966.77156,756.61748,062.63443,844.38731,753.24826,271.52
Brutowinst 94,515.57278,100.79962,337.78648,991.12568,433.3174,450.14879,204.80676,178.30262,678.77954,165.86951,088.74546,572.19868,863.28557,120.65553,346.83245,637.18234,656.42
Brutowinstmarge 0.5570.5130.4530.3830.4580.5050.5650.5360.5010.5140.4930.4630.5480.5430.5490.590.569
Onderzoek- en ontwikkelingskosten 2,969.8481,711.2852,064.654535.057676.467140.5780023.8787.5100.8081,075.3741,185.3871,789.4231,741.3731,401.709552.828
Algemene en administratieve kosten 4,176.754,665.6313,882.74613,958.44714,704.03213,545.41413,737.69712,285.60112,647.828,916.9619,775.44911,258.75911,665.1938,791.4478,703.476,002.4674,258.97
Verkoop- en marketingkosten 68,301.16742,666.36641,650.86917,531.6111,218.28712,145.2113,375.70212,388.40810,337.9218,472.6487,244.4517,636.57911,098.3729,081.8699,728.9548,153.4724,548.651
Verkoop-, algemene en administratieve kosten 89,224.01547,331.99745,533.61531,490.05725,922.31925,690.62427,113.39924,674.00922,985.74117,389.60917,019.918,895.33822,763.56517,873.31618,432.42414,155.9398,807.621
Overige kosten -1,357.94322,623.62820,620.32145,930.0556,128.8761,643.3735,022.496677.474-6,133.319257.8031,279.31844.83837.46-327.374-790.642-1,345.737-594.073
Bedrijfskosten 93,551.80671,666.9168,218.5977,955.16482,727.66269,513.23871,731.54866,120.55565,149.03450,439.80646,983.32150,296.97657,915.14547,983.17246,580.5237,759.19424,884.314
Bedrijfsresultaat 963.7656,433.888-5,880.804-28,964.039-14,294.3524,936.917,473.25810,057.747-2,470.2553,726.0634,105.424-3,724.77810,761.9799,137.4836,766.3117,877.9879,772.108
Bedrijfsresultaat ratio 0.0060.042-0.043-0.227-0.0960.0330.0530.071-0.020.0350.04-0.0370.0860.0870.070.1020.16
Totaal overige inkomsten en kosten netto -5,745.399-3,781.682-717.3151,669.528-4,889.639-3,044.2932,633.214-1,870.268-7,982.487-3,039.707-3,008.403-5,768.642-5,113.532-3,640.78-3,595.143-2,031.218-1,155.479
Inkomen voor belasting -4,781.6342,652.206-6,598.119-27,294.511-19,183.9911,892.61710,106.4728,187.479-10,452.742686.3561,097.021-9,493.425,834.6085,496.7033,171.1695,846.778,616.627
Inkomen voor belasting ratio -0.0280.017-0.048-0.213-0.1280.0130.0720.058-0.0840.0070.011-0.0940.0460.0520.0330.0760.141
Belastingkosten 92.609-5,323.849206.138458.5031,648.8511,564.7671,975.2391,713.3857,411.37729.354895.7093,252.9351,767.523,165.529370.317983.4412,033.432
Nettowinst -4,524.8377,867.987-6,804.257-27,753.014-20,832.842988.2697,807.4986,745.899-16,135.461761.491,025.971-12,273.3594,5543,067.8532,940.9814,863.3296,583.195
Nettowinstmarge -0.0270.052-0.049-0.217-0.1390.0070.0560.047-0.1290.0070.01-0.1220.0360.0290.030.0630.108
WPA (Winst Per Aandeel) -134.35232.74-201.27-948.05-832.0439.94305.36292.95-758.8635.4948.2-577.27257.71188.31181.35327529.74
Verwaterde WPA -134.35232.74-201.27-948.05-832.0439.94305.36292.95-758.8635.4948.2-577.27257.71188.31181.35327529.74
EBITDA 4,526.45210,753.651-254.678-23,090.595-8,635.7648,651.83814,708.62812,944.314-6,266.9926,536.0317,822.352-1,295.55513,562.96812,759.07510,132.2119,525.82510,871.716
EBITDA ratio 0.0270.071-0.002-0.181-0.0580.0590.1050.091-0.050.0620.075-0.0130.1080.1210.1040.1230.178